Herpesvirus type 2 has been implicated as a possible etiological agent in carcinoma of the cervix. Neutralizing antibodies to herpesvirus type 2 have been found more frequently among women with carcinoma of the cervix than among control women in certain, but not all, populations (16, 19, 20, 25) . In addition, it has been reported that cervical anaplasia occurs more frequently among women with genital herpes than among control women and that cells from cervical neoplasms contain herpesvirus-specific antigens (17, 26) .
By means of the immunofluorescence test using viable cells, several oncogenic and cytolytic viruses have been shown to induce formation of specific antigens on the surface of infected cells (2, 4, 7, 9, 10, 12, 13, 27, 28) . These include, among the members of the herpesvirus group, Epstein-Barr virus (EBV) and herpesvirus of Marek's disease (2, 4, 12) , which are associated with lymphoproliferative diseases. Patients with Burkitt's lymphoma or nasopharyngeal carcinoma may possess high levels of antibodies to surface antigens of cells infected with EBV, and the titers of these antibodies have been reported to fluctuate during regressions and recurrences of the tumors (11) .
Infection of cells with herpesvirus type 1 has been reported to induce formation of specific surface antigens (22) . Because of the importance of herpesviruses in human disease, the present study was undertaken to examine surface antigens induced by herpesvirus type 1 or 2, which can be demonstrated by means of the immunofluorescence reaction with various human sera.
MATERLALS AND METHODS
Cell cultures. Primary rabbit kidney (PRK), chick embryo (CE), and human embryonic kidney (HEK) cell cultures were prepared and maintained as previously described (5, 15) .
Virus and virus assays. Herpesvirus type 1 strains KOS and a mutant C2b, which replicates in CE cells, have been described elsewhere (15, 18) . Type 2 herpesvirus, strain SAV, isolated from a vulvar lesion, was used throughout the study.
Stocks of herpesvirus type I were prepared in passaged HEK cell cultures (15) . Preparation of type 2 virus stocks differed from preparation of type 1 virus stocks in that type 2 preparations were subjected to only one cycle (instead of three) of freezing and thawing, followed by ultrasonic treatment for 30 sec. Virus stocks were placed in ampoules and stored at -70 C.
Strain KOS was quantitated by the plaque count method in PRK cell cultures, and strain C2b was assayed in CE cell cultures ( 15 Study groups. Sera from selected groups were tested for neutralizing antibodies to types 1 and 2 herpesvirus and antibodies to surface antigens of herpesvirusinfected cells. Sera were obtained from 20 patients from whom type 1 herpesvirus had been isolated, and 20 sera were obtained from patients with genital herpes from whom type 2 herpesvirus had been isolated. There were sera from 30 women with histologically proven invasive carcinoma of the cervix and 30 control women. These sera were collected in three geographic areas. In two areas, the patients were Caucasian, and in these areas the occurrence of antibodies to herpesvirus type 2 among cancer patients had been found to be between 37 and 50%0. In the other area, the patients were Negro, and 83% had antibodies to the virus.
RESULTS
Demonstration of surface immunofluorescence in cells infected with type 1 or type 2 herpesvirus. By use of a 1: 4 dilution of serum obtained from a patient with a known past infection with herpesvirus type 1, surface antigens could be demonstrated on CE cells infected with type 1 herpesvirus. Specific fluorescence was not observed until 6 hr after infection of the cultures with 1 to 2 PFU of the C2b strain per cell. The fluorescence pattern at 6 hr was characterized by many bright granules spread evenly over the surface of the infected cells. By 10 hr after infection, the granularity was replaced by a more diffuse pattern of fluorescence in which the periphery of the cells displayed bright rings. An example of this pattern of fluorescence is shown in Fig. 1A .
Infection of CE cell cultures with the SAV strain of herpesvirus type 2 resulted in surface fluorescence when serum collected from a patient with a known type 2 herpesvirus infection was used. The reaction was again first noted at about 6 hr after infection but, unlike type 1 virus, the fluorescence pattern remained granular throughout the 24 hr of observation (Fig. iB) .
Infection (Table 1) . The correlation between results obtained by the two methods is further illustrated by the similarity of the mean II/I index values obtained for the groups studied (Table 1) . When the 11,/I indices obtained by microneutralization test and by the surface fluorescence test of women with cervical cancer and of control women were compared, no differences were found. As can be seen in Fig. 4 , regression lines obtained from the examination of the sera from 30 women with cervical cancers, represented by the solid line, and 30 control women, represented by the broken line, were similar. Thus, women with carcinoma of the cervix could not be distinguished from control women by these antibody titrations. DISCUSSION In confirmation and extension of previous studies (6, 14) , the data presented indicate that The antigens appearing at the cell surface required infectious virus and the synthesis of new proteins. The reaction did not appear to be due to virus particles, since the surface antigens appeared before the release of infectious virus, and electron microscopy of CE cells 24 hr after infection with either C2b or SAV strains did not reveal significant numbers of virus particles adhering to the cell surface (unpublished data). In addition, alteration of the membrane of cells infected with herpesvirus has been demonstrated by a number of techniques (8, 22, 23) . Using a complementdependent cytolytic technique, Roizman (22) has presented evidence that the surface membrane changes are virus-specific, and that the same antigens are found in the envelope of the virion. The level of cytolytic antibody in sera obtained from herpesvirus-infected rabbits correlated with the titer of neutralizing antibody (24) . The data presented in our study of 100 human sera confirm the correlation between antibody activity to cell surface antigens and neutralizing antibody activity. This correlation supports the hypothesis that the antigens demonstrable at the surface of infected cells are similar to those incorporated into the herpesvirion envelope.
The primary objective of this study was to determine whether the surface fluorescence test couild be used as a tool to distinguish women with cervical cancer from control women. This approach was taken because of reports showing that surface antigens of cells infected with certain oncogenic viruses could be demonstrated by using the serum of animals immune to transplantation of tumor cells induced by the virus (3). In addition, patients with Burkitt's lymphoma and nasopharyngeal carcinoma have been found to have higher antibody titers to EBV cell surface antigens than patients without these neoplasms (11) .
Previously, a greater occurrence of antibodies to herpesvirus type 2, as defined by the relative antibody titers to herpesvirus type 1 and type 2, was found among Negro women than among control women matched for race, age, and social level (16, 20, 25) . Among Caucasian women, antibodies to the virus were found in less than half of the women with cervical cancer (19 
